The emergence of Aeromonas spp. as human pathogens of intense clinical significance can hardly be disputed. Aeromonads have been documented in recent times as both primary pathogens in previously healthy human hosts and as secondary pathogens in compromised hosts (5) . As primary pathogens, Aeromonas spp. often gain entrance into the body as a result of contact between water and wounded surface tissue (10) . Seasonal variations in both aquatic environments (25) and clinical presentations (9) have been described. Aeromonas isolates from clinical presentations have most often been recovered from gastrointestinal and intraabdominal sites (13, 24, 28) .
Although generally not regarded as part of the normal flora, aeromonads occur in the stools of up to 3% of asymptomatic individuals (8) . Among symptomatic individuals, however, acute diarrheal syndromes associated with Aeromonas spp. in the stool have been extensively cited (3, 7, 14, 20, 23, 27) . Aeromonads have also been isolated from urine (13, 26) , sputum (26) (27) (28) , an eye wound (28) , exudate from chronic otitis media (28) , and nose and throat cultures (27, 28) . In compromised hosts, Aeromonas sepsis (1), meningitis and sepsis (22) , and endocarditis (5) (12) .
All FAME samples were analyzed via gas-liquid chromatography with a fused silica, wide-bore capillary column (30 m by 0.75 mm [inside diameter]) coated with 1.0-,um bonded methyl silicone (SPB-1) as the stationary phase (Supelco, Inc., Bellefonte, Pa.). The column was installed in a Sigma 3B gas chromatograph (The Perkin-Elmer Corp., Norwalk, Conn.) equipped with a flame ionization detector. This packed-column instrument was adapted to perform widebore capillary analyses with a wide-bore capillary conversion kit (Supelco). For FAME analyses, the column was temperature programmed from 150 to 240°C at 6°C/min and was maintained at 240°C for 7 min. The injector temperature was 250°C, and the detector temperature was 260°C. The carrier gas was nitrogen at a flow rate of approximately 5 ml/min at the injection port. We used a makeup gas kit (Supelco) to provide a booster flow of nitrogen at approximately 48 ml/min to the detector end of the column to minimize sample band spreading before passage through the flame ionization detector. Sample sizes varied from 0.5 to 0.75 ,ul. Integration of all chromatographic profiles was performed by a model 3390A integrator (Hewlett-Packard Co., Avondale, Pa.).
Tentative identification of FAME peaks was achieved by comparison of sample retention times with the retention times of commercially prepared FAME standard mixes and individual hydroxy FAMEs (Supelco). Final identification was achieved through trifluoroacetylation of hydroxy acids (17) , hydrogenation of unsaturated acids (17) , and bromination (2) .
A chromatographic profile representative of those obtained for the 12 clinical aeromonads studied is depicted in Fig. 1 . The minor hydroxy peak, 3-OH 12:0, was always present at a level of less than 0.5% of total peak area, with the major 3-OH 14:0 species generally accounting for 6.5 to 9% of total peak area.
Although hydroxy fatty acid presence in Aeromonas spp. has been previously documented by Lambert et al. (11) Among the A. hydrophila, A. sobria, and A. caviae isolates studied, qualitatively similar gas-liquid chromatographic profiles were obtained for all FAME species. It therefore seems unlikely that differentiation of the clinical isolates on this basis can be effected. The results presented in this investigation, however, do indicate that gas-liquid chromatographic analysis can serve to separate the motile aeromonads of clinical origin as a group from those nonclinical aeromonads whose FAME profiles have been previously examined and reported in the literature.
